Notice2022-03901
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 24, 2022
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Johnson Matthey Pharmaceutical Materials Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 37 (Thursday, February 24, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10389]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03901]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-956]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Johnson Matthey Pharmaceutical Materials Inc. has applied to
be registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to Supplemental Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 25, 2022.
Such persons may also file a written request for a hearing on the
application on or before April 25, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 5, 2021, Johnson Matthey Pharmaceutical
Materials Inc., 25 Patton Road, Devens, Massachusetts 01434, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................. 1100 II
Methylphenidate......................... 1724 II
Nabilone................................ 7379 II
Hydrocodone............................. 9193 II
Levorphanol............................. 9220 II
Thebaine................................ 9333 II
Alfentanil.............................. 9737 II
Remifentanil............................ 9739 II
Sufentanil.............................. 9740 II
------------------------------------------------------------------------
The company plans to support its other manufacturing facilities
located in West Deptford, New Jersey and Conshohocken, Pennsylvania
with manufacturing and analytical testing. In reference to drug code
9333 as bulk, the company plans to manufacture a Thebaine derivative
for distribution to its customers. No other activities for these drug
codes are authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-03901 Filed 2-23-22; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on February 24, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.